Abstract:Ochratoxin A (OTA) is one of the most abundant mycotoxin contaminants in food stuffs and possesses carcinogenic, nephrotoxic, teratogenic, and immunotoxic properties. Specifically, a major concern is severe nephrotoxicity, which is characterized by degeneration of epithelial cells of the proximal tubules and interstitial fibrosis. However, the mechanism of OTA toxicity, as well as the genetic risk factors contributing to its toxicity in humans has been elusive due to the lack of adequate models that fully recapitulate human kidney function in vitro. The present study attempts to evaluate dose-response relationships, identify the contribution of active transport proteins that govern the renal disposition of OTA, and determine the role of metabolism in the bioactivation and detoxification of OTA using a 3D human kidney proximal tubule microphysiological system (kidney MPS). We demonstrated that LC50 values of OTA in kidney MPS culture (0.375-1.21 μM) were in agreement with clinically relevant toxic concentrations of OTA in urine. Surprisingly, no enhancement of kidney injury biomarkers was evident in the effluent of the kidney MPS after OTA exposure despite significant toxicity observed by LIVE/DEAD staining. Instead, these biomarkers decreased in an OTA concentration-dependent manner. Furthermore, the effect of 1-aminobenzotriazole (ABT) and 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol (NBDHEX), pan-inhibitors of P450 and glutathione S-transferase (GST) enzymes, respectively, on OTA-induced toxicity in kidney MPS was examined. These studies revealed significant enhancement of OTA-induced toxicity by NBDHEX (3 μM) treatment, whereas ABT (1 mM) treatment decreased OTA-induced toxicity, suggesting roles for GSTs and P450 enzymes in the detoxification and bioactivation of OTA, respectively. Analysis of transcriptional changes using RNA-sequencing of kidney MPS treated with different concentrations of OTA revealed downregulation of several nuclear factor (erythroid derived-2)-like 2 (NRF2)-regulated genes by OTA treatment, including GSTs. The transcriptional repression of GSTs is likely playing a key role in OTA toxicity via attenuation of glutathione conjugation/detoxification. The sequential molecular events may explain the mechanism of toxicity associated with OTA. Additionally, OTA transport studies using kidney MPS in the presence and absence of probenecid (1 mM) suggested a role for organic anionic membrane transporter(s) in the kidney specific disposition of OTA. Our findings provide a clearer understanding of the mechanism of OTA-induced kidney injury, which may support changes in risk assessment, regulatory agency policies on allowable exposure levels, and determination of the role of genetic factors in populations at risk for OTA nephrotoxicity.

Ochratoxin A Induced Premature Senescence in Human Renal Proximal Tubular Cells.

DNA Damage and S Phase Arrest Induced by Ochratoxin A in Human Embryonic Kidney Cells (HEK 293)

Ochratoxin A induces human kidney tubular epithelial cell apoptosis through regulating lipid raft/ PTEN / AKT signaling pathway

Ochratoxin A (OTA) Causes Intestinal Aging Damage Through the NLRP3 Signaling Pathway Mediated by Calcium Overload and Oxidative Stress

Ochratoxin A Induces Nephrotoxicity and Immunotoxicity Through Different MAPK Signaling Pathways in PK15 Cells and Porcine Primary Splenocytes.

Ochratoxin A Induces Rat Renal Carcinogenicity with Limited Induction of Oxidative Stress Responses.

Ochratoxin A Induces Apoptosis in Neuronal Cells

Ochratoxin A Induces Cytoprotective Autophagy Via Blocking AKT/mTOR Signaling Pathway in PK-15 Cells.

In vitro and in vivo induction of ochratoxin a exposure-related micronucleus formation in rat proximal tubular epithelial cells and expression profiling of chromosomal instability-related genes

Ochratoxin A induces glomerular injury through activating the ERK/NF-κB signaling pathway

Regulation of Taurine in OTA-induced Apoptosis and Autophagy.

Microphysiological system modeling of ochratoxin A-associated nephrotoxicity

Mitigation of Cell Apoptosis Induced by Ochratoxin A (OTA) is Possibly Through Organic Cation Transport 2 (OCT2) Knockout.

Limited Link Between Oxidative Stress and Ochratoxin A-Induced Renal Injury in an Acute Toxicity Rat Model.

Excessive ER-phagy contributes to ochratoxin A-induced apoptosis

Ochratoxin A Induced Differentiation Nephrotoxicity in Renal Tubule and Glomeruli Via Autophagy Differential Regulation

Apoptosis Signal-regulating Kinase 1 Promotes Ochratoxin A-induced Renal Cytotoxicity

Lonp1 and Sig-1R contribute to the counteraction of ursolic acid against ochratoxin A-induced mitochondrial apoptosis

An Itraq-Based Mitoproteomics Approach for Profiling the Nephrotoxicity Mechanisms of Ochratoxin A in HEK 293 Cells

Involvement of multiple epigenetic mechanisms by altered DNA methylation from the early stage of renal carcinogenesis before proliferative lesion formation upon repeated administration of ochratoxin A

Ochratoxin A induces nephrotoxicity in vitro and in vivo via pyroptosis